Post-stroke Seizure and Epilepsy Following Thrombolytic Therapy

Last updated: January 31, 2025
Sponsor: Mazandaran University of Medical Sciences
Overall Status: Completed

Phase

N/A

Condition

Epilepsy

Stroke

Cerebral Ischemia

Treatment

N/A

Clinical Study ID

NCT06812000
17989
  • Ages > 18
  • All Genders

Study Summary

This retrospective cohort study was conducted by reviewing the records of consecutive patients referred to Bu Ali Sina Hospital from 2016 to 2023, who were hospitalized with a diagnosis of ischemic stroke. The records of all patients treated with intravenous alteplase during the above period were extracted, and the relevant characteristics were recorded in a questionnaire. In each year, patients with ischemic stroke who were not treated with alteplase but were hospitalized at the Bu Ali Center were selected in a similar number to patients who received alteplase in the same year, and the relevant information was extracted from their records and recorded in a questionnaire. The incidence of post-stroke seizures and epilepsy was determined in both groups, and the factors associated with their incidence were studied and compared.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of ischemic stroke

  • Treatment with IV alteplase

Exclusion

Exclusion Criteria:

  • History of epilepsy

  • Taking antiseizure medications

  • Unavailable patients

  • Unreliability of recorded patients' files

Study Design

Total Participants: 199
Study Start date:
April 14, 2024
Estimated Completion Date:
January 12, 2025

Connect with a study center

  • Mazandaran University of Medical Sciences

    Sari, Mazandaran
    Iran, Islamic Republic of

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.